A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism

NCT07470983 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Aldosteronism

Interventions

DRUG: HRS-1780 Tablets
DRUG: Placebo

Sponsor

Shandong Suncadia Medicine Co., Ltd.